References
- Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MCB, Su J, Xu F, Weinstock H. Sexually transmitted infections among US women and men. Sex Transm Dis. 2013;40(3):187–193. doi:10.1097/OLQ.0b013e318286bb53.
- Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018;(5). doi:10.1002/14651858.CD009069.pub3.
- Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination — updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405–1408. doi:10.15585/mmwr.mm6549a5.
- HHS, CDC, NCHHSTP. CDC FACT SHEET incidence, prevalence, and cost of sexually transmitted infections in the United States; 2008 [ accessed 2018 Sept 29]. https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/sti-incidence-prevalence-cost-fact-sheet-508.pdf.
- Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — united States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(33):874–882. doi:10.15585/mmwr.mm6633a2.
- Goyal V, Mattocks KM, Sadler AG. High-risk behavior and sexually transmitted infections among U.S. active duty servicewomen and veterans. J Womens Health (Larchmt). 2012;21(11):1155–1169. doi:10.1089/jwh.2012.3605.
- Agan BK, Macalino GE, Nsouli-Maktabi H, Wang X, Gaydos JC, Ganesan A, Kortepeter MG, Sanchez JL.. Human papillomavirus seroprevalence among men entering military service and seroincidence after ten years of service. Msmr. 2013;20(2):21–24. [ Accessed 2018 Sept 24]. http://www.ncbi.nlm.nih.gov/pubmed/23461307.
- Masel J, Deiss RG, Wang X, Sanchez JL, Ganesan A, Macalino GE, Gaydos JC, Kortepeter MG, Agan BK. Seroprevalence and seroincidence of herpes simplex virus (2006-2010), syphilis (2006-2010), and vaccine-preventable human papillomavirus subtypes (2000-2010) among US military personnel. Sex Transm Dis. 2015;42(5):253–258. doi:10.1097/OLQ.0000000000000277.
- Vaccine Recommendations by AOR | Health.mil. accessed 2018 Sept 24. https://www.health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Recommendations/Vaccine-Recommendations-by-AOR.
- LaRocque JD, Berry-Cabán CS. Human papilloma virus vaccination coverage among soldiers in a military treatment facility, 2007-2010. J Vaccines Vaccin. 2011;02:01. Gynecologic Oncology doi:10.4172/2157-7560.1000116.
- Shen-Gunther J, Shank JJ, Ta V. GardasilTM HPV vaccination: surveillance of vaccine usage and adherence in a military population. 2011. doi:10.1016/j.ygyno.2011.07.094.
- Maktabi H, Ludwig SL, Eick-Cost A, Yerubandi UD, Gaydos JC. Quadrivalent human papillomavirus vaccine initiation, coverage, and compliance among U.S. active component service women, 2006-2011. Msmr. 2012;19(5):16. [ accessed 2018 Sept 29]. http://www.ncbi.nlm.nih.gov/pubmed/22694590.
- Kwon PO, Lay J, Hrncir D, Levin L. Missed opportunities in human papillomavirus vaccination uptake among US air force recruits, 2009-2015. US Army Med Dep J. (1–18):67–75. [ accessed 2018 Nov 24]. http://www.ncbi.nlm.nih.gov/pubmed/30165724.
- Clark LL, Stahlman S, Taubman SB. Human papillomavirus vaccine initiation, coverage, and completion rates among U.S. active component service members, 2007-2017. MSMR. 2018;25(9):9–14. [ accessed 2018 Nov 24]. http://www.ncbi.nlm.nih.gov/pubmed/30272988.
- Population Representation in the Military Services 2011. [ accessed 2018 Nov 24]. https://www.cna.org/pop-rep/2011/.
- United States Department of Defense. Demographics - Profile of the military community. 2011. https://download.militaryonesource.mil/12038/MOS/Reports/2011_Demographics_Report.pdf
- United States Department of Veterans Affairs. Demographic characteristics of veterans who separated in 2011 and 2017. [ accessed 2018 Nov 24]. https://www.data.va.gov/dataset/demographic-characteristics-veterans-who-separated-2011-and-2017.
- United States Department of Veterans Affairs. VA utilization profile FY. 2016. Department of Veterans Affairs. https://www.va.gov/vetdata/
- Department of Veterans Affairs, Veterans Health Administration, Office of Patient Care Services, Health Services P-D, Program. Analysis of VA health care utilization among Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) Veterans. [ Accessed 2018 Sept 29]. http://www.publichealth.va.gov/epidemiology.
- Armed Forces Health Surveillance Center. Sexually transmitted infections, active component, U.S. Armed Forces, 2000-2012. Msmr. 2013;20(2):5–10. [ accessed 2018 Sept 29]. http://www.ncbi.nlm.nih.gov/pubmed/23461303.
- Wedel S, Navarrete R, Burkard JF, Clark MJ. Improving human papillomavirus vaccinations in military women. Mil Med. 2016;181(10):1224–1227. doi:10.7205/MILMED-D-15-00477.
- Buechel JJ, Connelly CD. Determinants of human papillomavirus vaccination among U.S. Navy personnel. Nurs Res. 2018;67(4):341–346. doi:10.1097/NNR.0000000000000282.
- Han JJ, Beltran TH, Song JW, Klaric J, Choi YS. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health and Nutrition Examination Survey (NHANES) 2013-2014. JAMA Oncol. 2017;3(6):810–816. doi:10.1001/jamaoncol.2016.6192.
- Nsouli-Maktabi H, Ludwig SL, Yerubandi UD, Gaydos JC. Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine. MSMR. 2013;20(2):17–20. [ Accessed 2018 Sept 29]. http://www.ncbi.nlm.nih.gov/pubmed/23461306.
- Schlecht NF, Diaz A, Shankar V, Szporn AH, Wu M, Nucci-Sack A, Peake K, Strickler HD, Burk RD. risk of delayed human papillomavirus vaccination in inner-city adolescent women. J Infect Dis. 2016;214(12):1952–1960. doi:10.1093/infdis/jiw486.
- Buechel J. Vaccination for human papillomavirus: immunization practices in the U.S. military. Clin J Oncol Nurs. 2018;22(1):104–107. doi:10.1188/18.CJON.104-107.
- Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016;34(9):1187–1192. doi:10.1016/j.vaccine.2016.01.023.